Contact

All Stories

  1. Psychometric properties of MG-ADL items and MG-ADL score: An assessment of distributional characteristics, validity and factor structure in two large datasets

    Article • Journal of the Neurological Sciences, August 2024, Elsevier

    Phd Sarah Dewilde

  2. The Burden Patients with Myasthenia Gravis Experience in Terms of Breathing, Fatigue, Sleep, Mental Health, Discomfort and Usual Activities in Comparison to the General Population

    Article • Advances in Therapy, November 2023, Springer Science + Business Media

    Phd Sarah Dewilde

  3. People Diagnosed with Myasthenia Gravis have Lower health-related quality of life and Need More Medical and Caregiver Help in Comparison to the General Population: Analysis of Two Observational Studies

    Article • Advances in Therapy, July 2023, Springer Science + Business Media

    Phd Sarah Dewilde

  4. Concordance between patient‐ and physician‐reported Myasthenia Gravis Activities of Daily Living (MG‐ADL) scores

    Article • Muscle & Nerve, May 2023, Wiley

    Phd Sarah Dewilde

  5. Association Between Myasthenia Gravis–Activities of Daily Living (MG-ADL) and EQ-5D-5L Utility Values: The Additional Effect of Efgartigimod on Utilities

    Article • Advances in Therapy, March 2023, Springer Science + Business Media

    Phd Sarah Dewilde

  6. Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MG

    Article • BMJ Open, January 2023, BMJ

    Phd Sarah Dewilde

  7. An EQ-5D-Y-3L Value Set for Belgium

    Article • PharmacoEconomics, November 2022, Springer Science + Business Media

    Phd Sarah Dewilde

  8. Exploration of the Reasons Why Health State Valuation Differs for Children Compared With Adults: A Mixed Methods Approach

    Article • Value in Health, July 2022, Elsevier

    Phd Sarah Dewilde

  9. Exploring the Comparability of Face-to-Face Versus Video Conference-Based Composite Time Trade-Off Interviews: Insights from EQ-5D-Y-3L Valuation Studies in Belgium and Spain

    Article • The Patient Patient-Centered Outcomes Research, February 2022, Springer Science + Business Media

    Phd Sarah Dewilde

  10. Thrombectomy is a cost-saving procedure up to 24 h after onset

    Article • Acta Neurologica Belgica, September 2021, Springer Science + Business Media

    Phd Sarah Dewilde

  11. Patient-reported impact of myasthenia gravis in the real world: protocol for a digital observational study (MyRealWorld MG)

    Article • BMJ Open, July 2021, BMJ

    Phd Sarah Dewilde

  12. Estimating health state utilities in hemophagocytic lymphohistiocytosis

    Article • Journal of Patient-Reported Outcomes, January 2021, Springer Science + Business Media

    Phd Sarah Dewilde

  13. Comparing two treatments in patients with Primary Hemophagocytic Lymphohistiocytosis (HLH)

    Article • Blood, November 2020, American Society of Hematology

    Phd Sarah Dewilde

  14. Evaluation of the cost-effectiveness of dexrazoxane for the prevention of anthracycline-related cardiotoxicity in children with sarcoma and haematologic malignancies: a European perspective

    Article • Cost Effectiveness and Resource Allocation, February 2020, Springer Science + Business Media

    Phd Sarah Dewilde

  15. The combined impact of dependency on caregivers, disability, and coping strategy on quality of life after ischemic stroke

    Article • Health and Quality of Life Outcomes, February 2019, Springer Science + Business Media

    Phd Sarah Dewilde

  16. The relationship between Home-time, quality of life and costs after ischemic stroke: the impact of the need for mobility aids, home and car modifications on Home-time

    Article • Disability and Rehabilitation, October 2018, Taylor & Francis

    Phd Sarah Dewilde, Yves Vandermeeren

  17. Hospital financing of ischaemic stroke: determinants of funding and usefulness of DRG subcategories based on severity of illness

    Article • BMC Health Services Research, May 2018, Springer Science + Business Media

    Phd Sarah Dewilde

  18. What Impact Does Venous Thromboembolism and Bleeding Have on Cancer Patients’ Quality of Life?

    Article • Value in Health, April 2018, Elsevier

    Phd Sarah Dewilde

  19. Modified Rankin scale as a determinant of direct medical costs after stroke

    Article • International Journal of Stroke, February 2017, SAGE Publications

    Phd Sarah Dewilde

  20. Health state utilities in non-small cell lung cancer: An international study

    Article • Asia-Pacific Journal of Clinical Oncology, March 2016, Wiley

    Phd Sarah Dewilde

  21. Utilities for treatment-related adverse events in type 2 diabetes

    Article • Journal of Medical Economics, October 2014, Informa Healthcare

    Phd Sarah Dewilde

  22. Bendamustine-rituximab: a cost-utility analysis in first-line treatment of indolent non-Hodgkin’s lymphoma in England and Wales

    Article • Journal of Medical Economics, January 2014, Taylor & Francis

    Phd Sarah Dewilde

  23. Investigating incoherence gives insight: clopidogrel is equivalent to extended-release dipyridamole plus aspirin in secondary stroke prevention

    Article • Journal of Clinical Epidemiology, August 2012, Elsevier

    Phd Sarah Dewilde

  24. Patient Preferences for First-Line Oral Treatment for Mild-to-Moderate Ulcerative Colitis

    Article • March 2012, Springer Science + Business Media

    Phd Sarah Dewilde

  25. Methylphenidate delivery mechanisms for the treatment of children with attention deficit hyperactivity disorder: Heterogeneity in parent preferences

    Article • International Journal of Technology Assessment in Health Care, July 2011, Cambridge University Press

    Phd Sarah Dewilde

  26. Cost-effectiveness of adjunctive eptifibatide in patients undergoing coronary stenting in Germany

    Article • The European Journal of Health Economics, April 2011, Springer Science + Business Media

    Phd Sarah Dewilde

  27. Eliciting health state utilities from the general public for severe chronic pain

    Article • The European Journal of Health Economics, August 2009, Springer Science + Business Media

    Phd Sarah Dewilde

  28. Cost-effectiveness of ziconotide in intrathecal pain management for severe chronic pain patients in the UK

    Article • Current Medical Research and Opinion, June 2009, Informa Healthcare

    Phd Sarah Dewilde

  29. Cost-effectiveness of warfarin: Trial versus “real-world” stroke prevention in atrial fibrillation

    Article • American Heart Journal, June 2009, Elsevier

    Phd Sarah Dewilde

  30. Preferences and utilities for the symptoms of moderate to severe allergic asthma

    Article • The European Journal of Health Economics, November 2007, Springer Science + Business Media

    Phd Sarah Dewilde

  31. Eliciting patient preferences for hormonal therapy options in the treatment of metastatic prostate cancer

    Article • Prostate Cancer and Prostatic Diseases, July 2007, Springer Science + Business Media

    Phd Sarah Dewilde

  32. Health state utilities for metastatic breast cancer

    Article • British Journal of Cancer, September 2006, Springer Science + Business Media

    Phd Sarah Dewilde

  33. The economic value of anti-IgE in severe persistent, IgE-mediated (allergic) asthma patients:adaptation of INNOVATE to Sweden

    Article • Current Medical Research and Opinion, August 2006, Taylor & Francis

    Phd Sarah Dewilde

  34. Impact of omalizumab on quality-of-life outcomes in patients with moderate-to-severe allergic asthma

    Article • Annals of Allergy Asthma & Immunology, February 2006, Elsevier

    Phd Sarah Dewilde

  35. The Cost-Effectiveness of Screening Programs Using Single and Multiple Birth Cohort Simulations: A Comparison Using a Model of Cervical Cancer

    Article • Medical Decision Making, October 2004, SAGE Publications

    Phd Sarah Dewilde

  36. Continuous retrograde blood cardioplegia is associated with lower hospital mortality after heart valve surgery

    Article • Journal of Thoracic and Cardiovascular Surgery, January 2003, Elsevier

    Phd Sarah Dewilde